Implantica publishes Year-end Report, January – December 2022 (Q4)
Implantica publishes Year-end Report, January – December 2022 (Q4)Significant events in the fourth quarter of 2022 · Spire Manchester Hospital is now performing RefluxStop™ procedures. Spire Manchester is part of Spire Healthcare Group, a network of 39 hospitals and 8 clinics across England, Wales and Scotland. · Implantica receives Global Health & Pharma’s Award; Most Innovative MedTech Company– Central Europe for 2022 based on a serious due diligence by GHP, identifying the high innovation level of Implantica. · Implantica attended the European Foregut Society (EFS) Conference